FR2571052B1 - Derives de 1,3-oxazolidine-2-one et leur procede de preparation - Google Patents

Derives de 1,3-oxazolidine-2-one et leur procede de preparation

Info

Publication number
FR2571052B1
FR2571052B1 FR8508128A FR8508128A FR2571052B1 FR 2571052 B1 FR2571052 B1 FR 2571052B1 FR 8508128 A FR8508128 A FR 8508128A FR 8508128 A FR8508128 A FR 8508128A FR 2571052 B1 FR2571052 B1 FR 2571052B1
Authority
FR
France
Prior art keywords
oxazolidine
derivatives
preparation process
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8508128A
Other languages
English (en)
Other versions
FR2571052A1 (fr
Inventor
Mitsuo Masaki
Haruhiko Shinozaki
Masaru Satoh
Naoya Moritoh
Koichi Hashimoto
Toshiro Kamishiro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Chemiphar Co Ltd
Original Assignee
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co Ltd filed Critical Nippon Chemiphar Co Ltd
Publication of FR2571052A1 publication Critical patent/FR2571052A1/fr
Application granted granted Critical
Publication of FR2571052B1 publication Critical patent/FR2571052B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR8508128A 1984-09-28 1985-05-30 Derives de 1,3-oxazolidine-2-one et leur procede de preparation Expired FR2571052B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59203624A JPS6183170A (ja) 1984-09-28 1984-09-28 新規な１，３−オキサゾリジン−２−オン誘導体およびその製造法

Publications (2)

Publication Number Publication Date
FR2571052A1 FR2571052A1 (fr) 1986-04-04
FR2571052B1 true FR2571052B1 (fr) 1988-03-04

Family

ID=16477122

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8508128A Expired FR2571052B1 (fr) 1984-09-28 1985-05-30 Derives de 1,3-oxazolidine-2-one et leur procede de preparation

Country Status (27)

Country Link
US (1) US4644063A (fr)
JP (1) JPS6183170A (fr)
KR (1) KR900004323B1 (fr)
AR (1) AR240924A1 (fr)
AT (1) AT392069B (fr)
AU (1) AU566419B2 (fr)
BR (1) BR8502707A (fr)
CA (1) CA1252092A (fr)
CH (1) CH663207A5 (fr)
CS (1) CS273606B2 (fr)
DE (1) DE3519261C2 (fr)
DK (1) DK165952C (fr)
ES (2) ES8800571A1 (fr)
FR (1) FR2571052B1 (fr)
GB (2) GB8512975D0 (fr)
HU (1) HU199132B (fr)
IN (1) IN162060B (fr)
IT (1) IT1208807B (fr)
MX (2) MX161397A (fr)
MY (1) MY102081A (fr)
NL (1) NL193191C (fr)
NZ (1) NZ212143A (fr)
PH (1) PH20852A (fr)
RO (1) RO91422B (fr)
SE (1) SE463100B (fr)
SU (2) SU1402263A3 (fr)
ZA (1) ZA854001B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6183147A (ja) * 1984-09-28 1986-04-26 Nippon Chemiphar Co Ltd 新規なアミノアルコール誘導体およびその製造法並びにそれを有効成分とするグルタミン酸遮断剤
JPH0759570B2 (ja) * 1986-05-06 1995-06-28 三井東圧化学株式会社 ２−オキサゾリジノン類の製造方法
JPH0713017B2 (ja) * 1986-06-18 1995-02-15 日本ケミファ株式会社 脳細胞保護作用を有する医薬組成物
DE3877470T2 (de) * 1987-09-10 1993-06-24 Merck Sharp & Dohme Oxazole und thiazole zur behandlung seniler demenz.
ATE106243T1 (de) * 1988-03-24 1994-06-15 Sankyo Co Verwendung von isoxazolinonen als cerebro-aktive medikamente.
JPH0314562A (ja) * 1988-04-11 1991-01-23 Nippon Chemiphar Co Ltd 新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤
US5187171A (en) * 1989-01-09 1993-02-16 G. D. Searle & Co. Use of a glycine b partial agonist as an antipsychotic
ATE170516T1 (de) * 1992-07-14 1998-09-15 Nippon Chemiphar Co Alkylendiaminderivate
US5698573A (en) * 1993-09-15 1997-12-16 Merck, Sharp & Dohme, Ltd. Imidazolone and oxazolone derivatives as dopamine antagonists
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
US6037354A (en) * 1997-06-18 2000-03-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US9717239B2 (en) 2013-03-14 2017-08-01 Akzo Nobel Chemicals International B.V. Cellulose ether as a drift control agent and rainfastness agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2437389A (en) * 1948-03-09 Oxazoeidones and erocesstok
DE1135461B (de) * 1959-05-08 1962-08-30 Knoll Ag Verfahren zur Herstellung von basisch substituierten Phthalimidinen
FR1301267A (fr) * 1961-04-04 1962-08-17 Science Union Et Compagnie Soc Nouveaux dérivés de l'oxazolidinone-2 et leurs procédés de préparation
US3131197A (en) * 1963-03-13 1964-04-28 Smith Kline French Lab 5-(3, 4-carbonyldioxyphenyl)-3-isopropyl-2-oxazolidone
US3576808A (en) * 1967-09-15 1971-04-27 Miles Lab N-4-phenyl-1-piperazinylalkyl-5-phenyl-oxazolidinones
GB1222708A (en) * 1968-10-22 1971-02-17 Delalande Sa Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
FR2179582B1 (fr) * 1972-04-13 1975-10-10 Synthelabo

Also Published As

Publication number Publication date
ES557075A0 (es) 1988-04-01
GB2165237A (en) 1986-04-09
ATA165685A (de) 1990-07-15
HUT39168A (en) 1986-08-28
AU4469785A (en) 1986-04-10
PH20852A (en) 1987-05-19
JPH0469150B2 (fr) 1992-11-05
GB8512975D0 (en) 1985-06-26
JPS6183170A (ja) 1986-04-26
IT8567500A0 (it) 1985-05-30
NL8501579A (nl) 1986-04-16
SU1431679A3 (ru) 1988-10-15
GB8513685D0 (en) 1985-07-03
RO91422A (fr) 1987-06-30
AU566419B2 (en) 1987-10-22
GB2165237B (en) 1987-12-09
US4644063A (en) 1987-02-17
CS273606B2 (en) 1991-03-12
ES8802152A1 (es) 1988-04-01
IT1208807B (it) 1989-07-10
AT392069B (de) 1991-01-25
SU1402263A3 (ru) 1988-06-07
DE3519261A1 (de) 1986-04-10
CH663207A5 (fr) 1987-11-30
AR240924A2 (es) 1991-03-27
CS392785A2 (en) 1990-08-14
DK165952B (da) 1993-02-15
KR900004323B1 (ko) 1990-06-22
HU199132B (en) 1990-01-29
MY102081A (en) 1992-03-31
KR860002502A (ko) 1986-04-26
DE3519261C2 (de) 1997-01-16
MX21592A (es) 1994-01-31
CA1252092A (fr) 1989-04-04
NL193191B (nl) 1998-10-01
ES543517A0 (es) 1987-11-01
SE463100B (sv) 1990-10-08
MX161397A (es) 1990-09-20
NZ212143A (en) 1987-11-27
RO91422B (ro) 1987-07-02
DK230185A (da) 1986-03-29
NL193191C (nl) 1999-02-02
BR8502707A (pt) 1986-05-27
SE8502525L (sv) 1986-03-29
ZA854001B (en) 1986-01-29
DK165952C (da) 1993-07-05
FR2571052A1 (fr) 1986-04-04
IN162060B (fr) 1988-03-19
AR240924A1 (es) 1991-03-27
DK230185D0 (da) 1985-05-23
SE8502525D0 (sv) 1985-05-22
ES8800571A1 (es) 1987-11-01

Similar Documents

Publication Publication Date Title
FR2555585B1 (fr) Derives de la 1-heteroaryl-4 ((2,5-pyrrolidinedion-1-yl) alkyl )piperazine, leur procede de preparation et leur application pharmacologique
FR2603586B1 (fr) Composes derives de l'imidazoquinolinylether, et leur procede de preparation
BE892758A (fr) Derives phenylcyclobutyliques, leur procede de preparation et leur application therapeutique
FR2504920B1 (fr) Derives phenylcyclobutyliques, leur procede de preparation et leur application therapeutique
FR2634122B1 (fr) Derives de furanne et leur procede de preparation
FR2349579A1 (fr) Derives de 1,2-dihydronaphtalene et leur procede de preparation
FR2506306B1 (fr) Nouveaux derives de l'amidinopiperidine, leur procede de preparation et leur application en therapeutique
FR2571052B1 (fr) Derives de 1,3-oxazolidine-2-one et leur procede de preparation
BE882133A (fr) Derives d'acides 1-omega-mercaptoacyl)-4,5-dihydropyrazole-5-carboxyliques et leur procede de preparation
BE896478A (fr) DERIVES N-CARBAMOYLE D'ISOTHIAZOLO-(5,4b) PYRIDINE ONE-3 ET LEUR PROCEDE DE PREPARATION
MC1692A1 (fr) Procede de preparation de derives de phenyltetraenyle derives de phenyltetraenyle et leur application
BE895213A (fr) Derives d'azolyl-pentene, leur procede de preparation et leur utilisation
FR2559771B1 (fr) Derives de la 3-pyrrolidinopropiophenone et procede pour leur preparation
FR2553417B1 (fr) Derives de la chloro-4-furo-(3,4-c)-pyridine et leur procede de preparation
FR2572405B1 (fr) Nouveaux derives de la phenethylaminoalcoyle-6 furo-(3,4-c)-pyridine et leur procede de preparation
FR2599037B1 (fr) Dihydrogeno-1,3 disilazanes fonctionnels et procede pour leur preparation
FR2572075B1 (fr) Nouveaux derives de la 4-dioxino-(4,5-c)-pyridine et leur procede de preparation
BE894556A (fr) Derives de 1,2,3-thiadiazol-5-yl-uree, leur procede de preparation et leur utilisation
FR2533917B1 (fr) Derives 15-cycloaliphatiques de 13,14-bisdeshydro-carboprostacyclines et procede pour leur preparation
MA20531A1 (fr) Derives de benazole et leur preparation
FR2338942A1 (fr) Derives de 1,3-dihydro-1'-dimethylphosphinylalkyl-3-phenylspiro (isobenzofuranne-cycloazalcanes), leur procede de preparation et leur application
MA20386A1 (fr) Nouveaux derives de 1,4 dihydropridine,leur procede de preparation et leur application
BE894553A (fr) Derives de 1,2,3-thiadiazol-5-yl-uree, leur procede de preparation et leur utilisation
BE891580A (fr) Derives de piperazine 1,4-disubstitues et leur procede de preparation
FR2555180B1 (fr) Acides dialcoxy-4,5 dioxolanne-1,3 carboxylique-2, leurs derives, leur procede de preparation et leur application

Legal Events

Date Code Title Description
ST Notification of lapse